TeKBrace™
Complex extremity conditions (Musculoskeletal)
Pre-clinicalActive
Key Facts
Indication
Complex extremity conditions (Musculoskeletal)
Phase
Pre-clinical
Status
Active
Company
About TheraMicro
TheraMicro is a private, clinical-stage biotech leveraging microbiome science to develop novel therapeutics, initially focused on infectious diseases but with a clear expansion into musculoskeletal disorders. Its platform aims to modulate the human microbiome to address complex conditions, with its lead asset, TeKBrace™, targeting extremity musculoskeletal issues. The company is positioned at the intersection of two high-growth therapeutic areas but faces the challenge of bridging distinct scientific approaches. As a pre-revenue entity, its success hinges on clinical validation, strategic partnerships, and securing further funding to advance its pipeline.
View full company profile